IL25 and neoplasm: Notably, racemate of this dihydrobenzofuran lignan was recently reported as a highly promising antimetastatic agent that exerts this activity in vivo through its interaction with the tumor microenvironment by inducing the interleukin-25 (IL-25) secretion of tumor-associated fibroblasts [17].